TAU makes breakthrough in drug delivery to treat inflammatory bowel disease
To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and delivered it to animal models with Crohn's disease.
RESEARCHER DAN PEER: ‘We discovered that altering the proportions of lipids comprising the nanoparticles determines their destination in the bloodstream.’ (photo credit: TEL AVIV UNIVERSITY)ByJUDY SIEGEL-ITZKOVICH
